Biventricular Support in Patients With Profound Car-Diogenic Shock

Magliato, Kathy E.; Kleisli, Thomas; Soukiasian, Harmik J.; Tabrizi, Robert; Coleman, Bernice; Hickey, Ann; Czer, L.; Blanche, Carlos; Cheng, Wen; Fontana, Gregory P.; Kass, Robert M.; Raissi, Sharo; Trento, Alfredo

doi:10.1097/00002480-200203000-00080

Cited by 35 publications

(36 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Prior experiences with LVAD support failure suggest the optimal management of severe RVF hinges on rapid identification and timely addition of biventricular support. 18,19 More recent studies have suggested that planned biventricular assist device implantations for patients at high risk for RVF have superior outcomes than those who are initially fitted with an LVAD and then proceed to rescue RVAD. 20 Our study is among the few studies to support a risk stratification tool that identifies not just the patients who will have any degree of RV dysfunction but also those who will require RVAD support.…”

Section: Discussionmentioning

confidence: 99%

Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation

Kang

Banerjee

2016

The Journal of Heart and Lung Transplantation

230

130

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation

Kang

Banerjee

2016

The Journal of Heart and Lung Transplantation

230

130

View full text Add to dashboard Cite

“…4). 13) As of September 2003, a total of 30 patients with advanced heart failure had been supported with the Thoratec implantable ventricular assist device (IVAD) for bridge-to-transplantation or post-cardiotomy ventricular failure in Europe and the United States.…”

Section: )mentioning

confidence: 99%

Current Mechanical Circulatory Support Devices for End Stage Heart Failure

Park

2009

Korean Circ J

View full text Add to dashboard Cite

Mechanical circulatory support is necessary when heart failure becomes refractory to medical support. It is typically instituted when organ dysfunction occurs as a result of hypoperfusion. Enthusiasm has recently developed for the role of mechanical circulatory support in the ever-growing population of heart failure patients. Indeed, efforts in developing this technology have allowed for the relatively recent development of a variety of complete circulatory support devices. The use of left ventricular assist devices (LVADs) in patients with advanced heart failure results in a clinically meaningful survival benefit and an improved quality of life, and LVADs could be an acceptable alternative therapy for selected patients who are not candidates for cardiac transplantation.

show abstract

“…Rapid evolution in mechanical circulatory support technology has allowed the implementation of cardiac assist devices within clinical management algorithms for patients with end-stage heart disease or cardiogenic shock. As such, this standard of care presents opportunities and challenges for all those involved in the care of this complex population (181).…”

Section: Medical Treatment Of Ahf Recommendationsmentioning

confidence: 99%